8-K current report · filed Oct 27, 2026

Chemed Corp (CHE) 8-K Current Report: October 27, 2026

Item 2.02Item EX-99.1CHE overview

Short answer

Chemed Corp (CHE) filed an 8-K current report with the SEC on October 27, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q3 2026 results for quarter ended September 30, 2026, covering Chemed’s latest operating performance.

Chemed Corp 8-K event analysis

AI summary of each reported item and its exhibits

Item 2.02 · Results of Operations and Financial Condition

  • Q3 2026 results for quarter ended September 30, 2026, covering Chemed’s latest operating performance
  • Press release furnished as Exhibit 99, containing the detailed financial results and management commentary

Item EX-99.1 · Exhibit EX-99.1

  • Q3 revenue $690.9M, up 10.6%; GAAP EPS $5.45, up 22.2%, adjusted EPS $6.75, up 28.1%
  • VITAS drove earnings: revenue $457.4M, ADC up 9.4%, adjusted EBITDA up 31.4% to $92.5M
  • VITAS Medicare Cap limitation fell to $828,000 from $6.1M, materially supporting quarterly revenue and margins
  • Roto-Rooter revenue rose 7.5%, but adjusted EBITDA fell 2.5% to $48.2M as margin declined 213 basis points to 20.6%
  • Roto-Rooter re-acquired California territories for approximately $62.5M, covering over 12 million people and adding branches in Sacramento and San Diego
  • Management expects full-year 2026 adjusted EPS at or slightly above the high end of prior guidance

Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean

Other Chemed Corp 8-K filings

Get the next CHE 8-K as it lands

Follow CHE for push alerts, or ask the research agent what this filing means.